NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-341-2008-0-PCT-02 Method For Boosting Immunity To Influenza Vaccine PCT PCT PCT/US2009/58464 Expired
NCI E-314-2008-0-PCT-02 Prediction Of Survival In Colon Adenocarcinoma Using The Expression Of Inflammatory Genes And MicroRNA21 PCT PCT PCT/US09/058425 Expired
NIAID E-300-2009-0-US-01 Neutralizing Antibodies to HIV-1 and Their Use US 61/246,039 Abandoned
NHLBI E-290-2009-0-US-01 Three Dimensional Motion Tracking From Volumetric Data US 61/245,586 Abandoned
NIAID E-123-2007-0-FR-27 Monoclonal Antibodies That Neutralize Anthrax Toxin FR EP 08730415.0 Abandoned
NIAID E-123-2007-0-DE-26 Monoclonal Antibodies That Neutralize Anthrax Toxin DE EP 08730415.0 Abandoned
NIAID E-123-2007-0-LI-31 Monoclonal Antibodies That Neutralize Anthrax Toxin LI EP 08730415.0 Abandoned
NIAID E-123-2007-0-IT-30 Monoclonal Antibodies That Neutralize Anthrax Toxin IT EP 08730415.0 Abandoned
NIAID E-123-2007-0-IE-29 Monoclonal Antibodies That Neutralize Anthrax Toxin IE EP 08730415.0 Abandoned
NIAID E-123-2007-0-CH-25 Monoclonal Antibodies That Neutralize Anthrax Toxin CH EP 08730415.0 Abandoned
NIAID E-123-2007-0-GB-28 Monoclonal Antibodies That Neutralize Anthrax Toxin GB EP 08730415.0 Abandoned
NIAID E-123-2007-0-SE-32 Monoclonal Antibodies That Neutralize Anthrax Toxin SE EP 08730415.0 Abandoned
NCI E-204-2009-0-US-01 Compositions and Methods for Silencing Genes Expressed in Cancer US 61/245,143 Abandoned
NCATS E-188-2009-0-US-01 Inhibitors Of Tau Protein Fibrillization. US 61/245,045 Abandoned
NCI E-256-2006-0-US-11 Self-assembling Nanoparticles Composed Of Transmembrane Peptides And Their Application For Specific Intra-tumor Delivery Of Anti-cancer Drugs US National Stage 12/513,950 9326950 Issued PDF
NCI E-006-2000-0-US-05 RECOMBINANT INFLUENZA VIRUSES EXPRESSING TUMOR-ASSOCIATED ANTIGENS AS ANTITUMOR AGENTS US DIV 12/564,702 8012490 Expired PDF
NCI E-295-2008-0-PCT-02 Novel Inhibitor Of NFkB PCT PCT PCT/US09/57761 Expired
NCI E-295-2008-0-EP-03 Nuclear Factor Kappa B Pathway Inhibitor Composition And Use Of Same EP National Stage 09792812.1 Abandoned
NCI E-221-2005-2-US-01 Fast Electron Paramagnetic Resonance Imaging (EPRI) Using CW CPR Spectrometer With Sinusoidal Rapid-scan And Digital Signal Processing US CIP 12/564,006 Abandoned
NCI E-295-2009-0-US-01 Method for Predicting of Patient Immune Responses Outcome To Treatment With Keyhole Limpet Hemocyanin US 61/243,849 Abandoned
NINDS E-251-2005-2-CA-04 Improvements To Vibro-tactile Stimulation Device CA National Stage 2737478 Issued
NIAID E-083-2006-0-US-03 Newly Discovered Bacterium In The Family Acetobacteraceae US ORD 12/225,615 9051573 Issued PDF
NINDS E-251-2005-2-AU-03 Improvements To Vibro-tactile Stimulation Device AU National Stage 2009293277 Issued
NINDS E-251-2005-2-PCT-02 Improvements To Vibro-tactile Stimulation Device PCT PCT PCT/US2009/057158 Expired
NCI E-171-2010-0-US-01 Cross-reactive HIV-1 Neutralizing Human Monoclonal Antibodies M66 Targeting The Gp41 MPER US 61/272,349 Abandoned
NCI E-215-2008-0-CA-03 Gene Expression Signature Of Genomic Instability In Breast Cancer CA National Stage 2737382 Abandoned
NCI E-215-2008-0-EP-04 Gene Expression Signature Of Genomic Instability In Breast Cancer EP National Stage 09792535.8 Abandoned
NCI E-215-2008-0-GB-06 Gene Expression Signature Of Genomic Instability In Breast Cancer GB EP 09792535.8 Abandoned
NCI E-215-2008-0-PCT-02 The Gene Expression Signature Of Genomic Instability In Breast Cancer Is An Independent Predictor Of Clinical Outcome PCT PCT PCT/US09/56931 Expired
NICHD E-147-1996-0-HK-26 ACTIVITY-DEPENDENT NEUROTROPHIC FACTOR (ADNF) III HK EP 10109508.4 Abandoned
NCI E-079-2009-1-US-01 Assays For Soluble IL-15 Receptor Alpha US 61/242,595 Abandoned
NICHD E-161-2009-0-US-01 Polarization Adapter For Colposcope US 61/242,652 Abandoned
NCI E-162-2009-0-US-01 Inhibitors Of FKBP52-Mediated Regulation Of Androgen Receptor Function US 61/242,541 Abandoned
CC E-195-2008-0-GB-08 System for performing biopsies GB EP 09766260.5 Issued
NIAID E-244-2009-0-US-03 Specific Labeling Reagents For The Detection Of Mycobacterial Infections US National Stage 13/395,382 Abandoned
NCI E-296-2009-0-US-01 Cellular Noncoding MiR-1293 And MiR-608 Are Inhibitors, Respectively, For The Expression Of KSHV VIL6 And Human IL6 US 61/241,678 Abandoned
NCI E-269-2009-0-US-01 Improved Pseudomonas Exotoxin A With Reduced Immunogenicity US 61/241,620 Abandoned
NIAID E-244-2009-0-US-01 Specific Labeling Reagents For The Detection Of Mycobacterial Infections US 61/241,741 Abandoned
NCI E-079-2009-0-US-01 Development Of A Sensitive ELISA For Detection Of Serum Level Of Soluble IL15 Receptor Alpha US 61/241,265 Abandoned
NHLBI E-243-2009-0-US-01 METHOD FOR THE TREATMENT OF PULMONARY DISEASE AND METHOD OF PRODUCING PROTEINS OF USE THEREIN US 61/241,311 Abandoned
NHGRI E-217-2007-0-US-07 N-acetyl Mannosamine As A Therapeutic Agent US National Stage 12/530,433 8410063 Issued PDF
NIDDK E-109-2006-0-US-02 Novel, Potent And Selective A3 Adenosine Receptor Antagonists US National Stage 12/530,086 9018371 Issued PDF
NHGRI E-037-2009-0-US-02 Marker Panels For Idiopathic Pulmonary Fibrosis Diagnosis And Evaluation US ORD 13/039,989 8846341 Issued PDF
NHGRI E-037-2009-0-PCT-03 Marker Panels For Idiopathic Pulmonary Fibrosis Diagnosis And Evaluation PCT PCT PCT/US2009/056085 Expired
NIA E-172-2009-0-US-01 METHODS FOR ENHANCING GENOME STABILITY AND TELOMERE ELONGATION IN EMBRYONIC STEM CELLS US 61/275,983 Abandoned
NIAMS E-210-2009-0-US-01 Disabling autophagy as a treatment for lysosomal storage diseases US 61/275,984 Abandoned
NCI E-211-2005-0-US-06 Use Of Chk2 Kinase Inhibitors For Cancer Treatment US National Stage 11/989,737 8912214 Abandoned PDF
NCI E-283-2008-0-GB-09 Method For Detection Of Cancer Based On Spatial Genome Organization GB EP 09792221.5 Abandoned
NCI E-283-2008-0-EP-05 Method For Detection Of Cancer Based On Spatial Genome Organization EP National Stage 09792221.5 Abandoned
NCI E-283-2008-0-DE-07 Method For Detection Of Cancer Based On Spatial Genome Organization DE EP 09792221.5 Abandoned